BamSEC and AlphaSense Join Forces
Learn More

Reviva Pharmaceuticals Holdings Inc. – Indentures

NASDAQ: RVPH    
Share price (3/30/26): $0.66    
Market cap (3/30/26): $4.253 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 14 pages Series H Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.2
from 8-K 14 pages Series G Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.1
from 8-K 17 pages Pre-Funded Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.2
from 8-K 14 pages Series F Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.1
from 8-K 14 pages Series E Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.2
from 8-K 14 pages Series D Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.1
from 8-K 14 pages Series C Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.1
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 19 pages Series B Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.1
from 8-K 20 pages Series a Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.4
from 8-K 3 pages Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Underwritten Offering on or About the Date Hereof (The “Offering”) by Reviva Pharmaceuticals Holdings, Inc. (The “Company”) of Its Common Stock, Par Value $0.0001 Per Share (“Common Stock”), and/or Other Securities of the Company (Collectively, the “Securities”)
12/34/56
EX-4.3
from 8-K 16 pages Representative’s Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.2
from 8-K 18 pages Prefunded Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.2
from 8-K 2 pages Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Registered Direct Offering on or About the Date Hereof (The “Offering”) by Reviva Pharmaceuticals Holdings, Inc. (The “Company”) of Its Common Stock, Par Value $0.001 Per Share (“Common Stock”), and/or Other Securities of the Company (Collectively, the “Securities”)
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Reviva Pharmaceuticals Holdings, Inc
12/34/56
EX-4.1
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 69 pages Reviva Pharmaceuticals Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Subordinated Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.5
from S-3 53 pages Reviva Pharmaceuticals Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Senior Debt Securities Cross Reference Sheet1 Between
12/34/56